Nature Reviews Rheumatology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

CAR T cells induce drug-free SLE remission

doi : 10.1038/s41584-022-00865-6

Volume 18 Issue 12, December 2022

Buy The Package and View The Article Online


Aberrant regulation of autophagy linked to OA

Jessica McHugh 

doi : 10.1038/s41584-022-00872-7

Buy The Package and View The Article Online


Single-cell-based platform maps response to candidate DMOADs

Sarah Onuora 

doi : 10.1038/s41584-022-00871-8

Buy The Package and View The Article Online


In-joint photocatalytic hydrogen production prevents RA in mice

Robert Phillips 

doi : 10.1038/s41584-022-00870-9

Buy The Package and View The Article Online


Target neutrophils to treat thrombotic APS?

Sarah Onuora 

doi : 10.1038/s41584-022-00866-5

Buy The Package and View The Article Online


CXCL5 effective in mouse model of SLE

Robert Phillips 

doi : 10.1038/s41584-022-00869-2

Buy The Package and View The Article Online


Small wonder: nanoparticles feed hydroxychloroquine to activated neutrophils

Somanathapura K. NaveenKumar & Jason S. KnightA

doi : 10.1038/s41584-022-00854-9

Buy The Package and View The Article Online


Paediatric glucocorticoid toxicity index: new possibilities in assessment

Charlotte King & Daniel B. HawcuttA

doi : 10.1038/s41584-022-00848-7

Buy The Package and View The Article Online


The value of comparative efficacy studies in informing rheumatology guidelines

Raveendhara R. Bannuru 

doi : 10.1038/s41584-022-00846-9

Buy The Package and View The Article Online


Keeping immunostimulatory self-RNA under the rADAR

Christine Wolf & Min Ae Lee-KirschA

doi : 10.1038/s41584-022-00859-4

Buy The Package and View The Article Online


Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis

Dan Fang, Beidi Chen, Alain Lescoat, Dinesh Khanna & Rong MuA

doi : 10.1038/s41584-022-00864-7

Systemic sclerosis (SSc) is a destructive connective tissue disease characterized by dysregulation of the immune system and fibrosis in the skin and internal organs. The pathogenesis of SSc is complex and remains to be determined. So far, limited specific disease-modifying treatments are available for the effective control of fibrosis in patients with SSc.

Buy The Package and View The Article Online


Age-related mechanisms in the context of rheumatic disease

Ghada Alsaleh, Felix C. Richter & Anna K. SimonA

doi : 10.1038/s41584-022-00863-8

Ageing is characterized by a progressive loss of cellular function that leads to a decline in tissue homeostasis, increased vulnerability and adverse health outcomes. Important advances in ageing research have now identified a set of nine candidate hallmarks that are generally considered to contribute to the ageing process and that together determine the ageing phenotype, which is the clinical manifestation of age-related dysfunction in chronic diseases.

Buy The Package and View The Article Online


A comprehensive guide for managing the reproductive health of patients with vasculitis

Catherine Sims & Megan E. B. ClowseA

doi : 10.1038/s41584-022-00842-z

Vasculitides and their therapies affect all areas of the reproductive life cycle. The ACR, EULAR and the Drugs and Lactation database offer guidance on the management of the reproductive health of patients with rheumatic diseases; however, these guidelines do not address patients with vasculitis specifically.

Buy The Package and View The Article Online


Precision medicine: the precision gap in rheumatic disease

Chung M. A. Lin, Faye A. H. Cooles & John D. IsaacsA

doi : 10.1038/s41584-022-00845-w

For many oncological conditions, the application of timely and patient-tailored targeted therapies, or precision medicine, is a major therapeutic development that has provided considerable clinical benefit.

Buy The Package and View The Article Online


Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

Rosaria Talarico, Silvia Aguilera, Tobias Alexander, Zahir Amoura, Ana M. Antunes, Laurent Arnaud, TadejAvcin,Lorenzo Beretta, Stefano Bombardieri, Gerd R. Burmester, Sara Cannizzo, Lorenzo Cavagna, Benjamin Chaigne, Alain Cornet,Nathalie Costedoat-Chalumeau, Andrea Doria, Alessandro Ferraris, Rebecca Fischer- Betz, João E. Fonseca, Charissa Frank,Andrea Gaglioti, Ilaria Galetti, Jürgen Grunert, Vera Guimarães, Eric Hachulla, Frederic Houssiau, Luca Iaccarino,Thomas Krieg, Marteen Limper, Fransiska Malfait, Xavier Mariette, Diana Marinello, Thierry Martin, Lisa Matthews,Marco Matucci-Cerinic, Alain Meyer, Carlomaurizio Montecucco, Luc Mouthon, Ulf Müller-Ladner, Simona Rednic,Vasco C. Romão, Matthias Schneider, Vanessa Smith, Alberto Sulli, Farah Tamirou, Domenica Taruscio, Anna V. Taulaigo,Enrique Terol, Angela Tincani, Simone Ticciati, Giuseppe Turchetti, P. Martin van Hagen, Jacob M. van Laar, Ana Vieira,Jeska K. de Vries- Bouwstra, Maurizio Cutolo and Marta Mosca

doi : 10.1038/s41584-022-00862-9

Buy The Package and View The Article Online


Author Correction: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

Laura C. Coates, Enrique R. Soriano, Nadia Corp, Heidi Bertheussen, Kristina Callis Duffin, Cristiano B. Campanholo,Jeffrey Chau, Lihi Eder, Daniel G. Fernández- �vila, Oliver FitzGerald, Amit Garg, Dafna D. Gladman, NitiGoel,Philip S. Helliwell, M. Elaine Husni, Deepak R. Jadon, Arnon Katz, Dhruvkumar Laheru, John Latella, Ying- Ying LeungChristine Lindsay, EnnioLubrano, LuisDanielMazzuoccolo , PhilipJ.Mease , Denis O’Sullivan, Alexis Ogdie,Wendy Olsder, Penelope Esther Palominos, Lori Schick, Ingrid Steinkoenig, Maarten de Wit, D.A.vanderWindt,Arthur Kavanaugh and the GRAPPA Treatment Recommendations domain subcommittees*

doi : 10.1038/s41584-022-00861-w

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?